Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity

Table 3

Comparison between liver enzymes and the rate of liver steatosis and the blood count between the three groups.

	Group 1		Group 2		Group 3
	Obese		Lean PCOS		Obese PCOS
	n		n		n
ASAT (U/l)	100	20.08±10.57	57	20.37±21.10	66	25.27±19.15
ALAT (U/l)	107	23.76±16.33^∧∧	61	17.57±9.65^∗∗	71	28.07±23.68
AP (U/l)	105	109.20±46.102	54	90.85±49.74^∗∗	62	120.58±55.07
GGT (U/l)	101	24.11±14.33^∧	56	16.97±11.62^∗∗∗	71	30.30±21.90
Steatosis (%)	35	57.1%^∧∧	13	7.7%^∗∗∗	25	72.0%
RBC	125	4.59±0.49	89	4.51±0.37	79	4.66±0.39
Hemoglobin	125	135.58±12.45	89	135.66±12.40	80	139.80±9.66^#
Hematocrite	104	0.40±0.04	86	0.40±0.03	74	0.41±0.03
MCV	88	86.05±7.12^∧∧∧	67	90.26±4.96	56	87.77±5.09
MCH	87	29.04±2.78^∧∧∧	67	30.48±1.66	56	29.66±1.71
MCHC	82	334.87±17.14	63	336.83±13.95	49	334.82±19.79
Platelets	106	306.96±82.36^∧∧	81	272.69±57.37	74	307.32±67.85
MPV	78	8.58±1.13	59	8.71±0.98	46	8.73±1.09
WBC	123	7.87±2.51^∧∧	87	6.88±2.14^∗	80	7.84±2.24
ESR	124	15.11±9.16^∧∧∧	83	7.75±5.51^∗∗∗	78	14.38±10.04

^#𝑃<0.05; between group 1and group 3.
* 𝑃<0.05; **𝑃<0.01; ***𝑃<0.001 between group 2 and group 3.
^∧𝑃<0.05; ^∧∧𝑃<0.01; ^{∧∧ ∧}𝑃<0.001 between group 1 and group 2.
n = number of patients.